Effect of dehydroepiandrosterone (DHEA) on memory and brain derived neurotrophic factor (BDNF) in a rat model of vascular dementia

Journal of Physiology and Pharmacology

Volumn 65, Issue 1, 2014, Pages 41-53

  Sakr, Hussein F ^a,b   Khalil, K I ^a   Hussein, A M ^a   Zaki, M S A ^b   Eid, R A ^b   Alkhateeb, M ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

Acetylcholine; Bilateral occlusion of the common carotid arteries; Brain derived neurotrophic factor; Dehydroepiandrosterone; Holeboard memory test; Vascular dementia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; COMPLEMENTARY DNA; DONEPEZIL; PRASTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; HISTOPATHOLOGY; LEARNING AND MEMORY TEST; MEMORY; MULTIINFARCT DEMENTIA; NONHUMAN; PSYCHOMETRY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TRANSMISSION ELECTRON MICROSCOPY; WORKING MEMORY;

ACETYLCHOLINE; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CAROTID ARTERY, COMMON; DEHYDROEPIANDROSTERONE; DEMENTIA, VASCULAR; DOPAMINE; HIPPOCAMPUS; INDANS; MALE; MEMORY; NEUROPROTECTIVE AGENTS; NEUROPSYCHOLOGICAL TESTS; NOREPINEPHRINE; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84896859599     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. de la Torre JC. Vascular basis of Alzheimer's pathogenesis. Ann NY Acad Sci 2002; 977: 196-215.
2. Farkas E, Luiten PG. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 2001; 64: 575-611.
3. Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann Nucl Med 2001; 15: 85-92.
4. Kumar P, Taha A, Sharma D, Kale RK, Baquer NZ. Effect of dehydroepiandrosterone (DHEA) on monoamine oxidase activity, lipid peroxidation and lipofuscin accumulation in aging rat brain regions. Biogerontology 2008; 9: 235-246.
5. Snyder PJ. Effects of age on testicular function and consequences of testosterone treatment. J Clin Endocrinol Metab 2001; 86: 2369-2372.
6. Krysiak R, Frysz-Naglak D, Okopie B. Current views on the role of dehydroepiandrosterone in physiology, pathology and therapy. Pol Merkur Lekarski 2008; 24: 66-71.
7. Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol 2009; 30: 65-91.
8. Rammouz G, Lecanu L, Papadopoulos V. Oxidative stressmediated brain dehydroepiandrosterone (DHEA) formation in Alzheimer's disease diagnosis. Front Endocrinol 2011; 2: 69.
9. Brown RC, Han Z, Cascio C, Papadopoulos V. Oxidative stress-mediated DHEA formation in Alzheimer's disease pathology. Neurobiol Aging 2003; 24: 57-65.
10. Yanase T, Fukahori M, Taniguchi S, et al. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia. Endocr J 1996; 43: 119-123.
11. Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 2004; 27: 589-594.
12. Numakawa T, Suzuki S, Kumamaru E, Adachi N, Richards M, Kunugi H. BDNF function and intracellular signaling in neurons. Histol Histopathol 2010; 25: 237-258.
13. Yamada K, Mizuno M, Nabeshima T. Role of brain-derived neurotrophic factor in learning and memory. Life Sci 2002; 70: 735-744.
14. Gorski JA, Balogh SA, Wehner JM, Jones KR. Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice. Neuroscience 2003; 121: 341-354.
15. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry J-M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109: 143-148.
16. Vawter MP, Van Ree JM. Hole board food search task in rats: effects of hole depths and food deprivation. Physiol Behav 1989; 45: 891-895.
17. Deutsch JA. The cholinergic synapse and the site of memory. Science 1971; 174: 788-794.
18. Dawson GR, Heyes CM, Iversen SD. Pharmacological mechanisms and animal models of cognition. Behav Pharmacol 1992; 3: 285-297.
19. Croxson PL, Browning PG, Gaffan D, Baxter MG. Acetylcholine facilitates recovery of episodic memory after brain damage. J Neurosci 2012; 32: 13787-13795.
20. Kety SS. The biogenic amines in the central nervous system: their possible roles in arousal, emotion and learning. In: The Neurosciences: Second Study Program. Schmidt FO (ed.), New York, Rockefeller Press, 1970, pp. 324-335.
21. Kandel ER. The molecular biology of memory storage: a dialogue between genes and synapses. Science 2001; 294: 1030-1038.
22. Walling SG, Harley CW. Locus ceruleus activation initiates delayed synaptic potentiation of perforant path input to the dentate gyrus in awake rats: a novel beta-adrenergic-and protein synthesis-dependent mammalian plasticity mechanism. J Neurosci 2004; 24: 598-560.
23. O'Carroll CM, Martin SJ, Sandin J, Frenguelli B, Morris RG. Dopaminergic modulation of the persistence of onetrial hippocampusdependent memory. Learn Mem 2006; 13: 760-767.
24. Lardy H, Henwood SM, Weeks CE. An acute oral gavage study of b-acetoxyandrost-5-ene-7, 17-dione (7-oxo-DHEAacetate) in rats. Biochem Biophys Res Commun 1999; 254: 120-123.
25. Lannert H, Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav Neurosci 1998; 112: 1199-1208.
26. Barakat-Walter I. Brain derived neurotrophic factor like immunoreactivity is localized mainly in small sensory neurons of rat dorsal root ganglia. J Neurosci Meth 1996: 68: 281-288.
27. de la Torre JC. Impaired cerebrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease. Ann NY Acad Sci 2002; 924: 136-152.
28. Farkas E, Institoris A, Domoki F, Mihaly A, Luiten PG, Bari F. Diazoxide and dimethyl sulphoxide prevent cerebral hypoperfusion-related learning dysfunction and brain damage after carotid artery occlusion. Brain Res 2004; 1008: 252-258.
29. Liu, HX, Zhang JJ, Zheng P, Zhang Y. Altered expression of MAP-2, GAP-43, and synaptophysin in the hippocampus of rats with chronic cerebral hypoperfusion correlates with cognitive impairment. Brain Res Mol Brain Res 2005; 139: 169-177.
30. Stasiak A, Mussur M, Unzeta M, Lazewska D, Kiec-Kononowicz K, Fogel WA. The central histamine level in a rat model of vascular dementia. J Physiol Pharmacol 2011; 62: 549-558.
31. Aly HF, Metwally FM, Ahmed HH. Neuroprotective effects of dehydroepiandrosterone (DHEA) in rat model of Alzheimer's disease. Acta Biochim Pol 2011; 58: 513-520.
32. McLean SL, Idris NF, Marsh S, Grayson B, Harte MK, Neill JC. Donepezil improves cognition in two cognitive domains and in two distinct models of cognitive impairment in female rats. Poster number: P.1.g.003. Eur Neuropsychopharmacol 01/2011; 21. DOI: 10.1016/S0924-977X(11)70524-7.
33. Ni JW, Matsumoto K, Li H-B, Murakami Y, Watanabe H. Neuronal damage and decrease of central acetylcholine level following permanent occlusion of bilateral common carotid arteries in rat. Brain Res 1995; 673: 290-296.
34. Rhodes ME, Li PK, Flood JF, Johnson DA. Enhancement of hippocampal acetylcholine release by the neurosteroid dehydroepiandrosterone sulfate: an in vivo microdialysis study. Brain Res 1996; 733: 284-286.
35. Zheng P. Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Prog Neurobiol 2009; 89: 134-152.
36. Bastianetto S, Ramassamy C, Poirier J, Quirion R. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res 1999; 66: 35-41.
37. Pakaski M, Feher A, Juhasz A, et al. Serum adipokine levels modified by donepezil treatment in Alzheimer's disease. J Alzheimers Dis 2014; 38: 371-377.
38. Leranth C, Petnehazy O, MacLusky NJ. Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J Neurosci 2003; 23: 1588-1592.
39. Leskiewicz M, Jantas D, Budziszewska B, Lason W. Excitatory neurosteroids attenuate apoptotic and excitotoxic cell death in primary cortical neurons. J Physiol Pharmacol 2008; 59: 457-475.
40. Leranth C, Prange-Kiel J, Frick KM, Horvath TL. Low CA1 spine synapse density is further reduced by castration in male non-human primates. Cereb Cortex 2004; 14: 503-510.
41. Smith MA, Makino S, Kvetnansky R, Post RM. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995; 15: 1768-1777.
42. Ueyama T, Kawai Y, Nemoto K, Sekimoto M, Tone S, Senba E. Immobilization stress reduces the expression of neurotrophins and their receptors in the rat brain. Neurosci Res 1997; 28: 103-110.
43. Cowansage KK, LeDoux JE, Monfils MH. Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. Curr Mol Pharmacol 2010; 3: 12-29.
44. Lipsky RH, Marini AM. Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann NY Acad Sci 2007; 1122: 130-143.
45. Mattson MP. Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann NY Acad Sci 2008; 1144: 97-112.
46. Chen J, Zacharek A, Zhang C, Jiang H, Li Y, Roberts C, Lu M, Kapke A, Chopp M. Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci 2005; 25: 2366-2375.
47. Madinier A, Bertrand N, Mossiat C, Prigent-Tessier A, Beley A, Marie C, Garnier P. Microglial involvement in neuroplastic changes following focal brain ischemia in rats. PLoS One 2009; 4; e8101.
48. Ploughman M, Windle V, MacLellan CL, White N, Dore JJ, Corbett D. Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke 2009; 40: 1490-1495.
49. Tian X, Hua F, Sandhu HK, et al. Effect of d-opioid receptor activation on BDNF-TrkB vs. TNF-a in the mouse cortex exposed to prolonged hypoxia. Int J Mol Sci. 2013; 14: 15959-15976.
50. Zoladz JA, Pilc A. The effect of physical activity on the brain derived neurotrophic factor: from animal to human studies. J Physiol Pharmacol 2010; 61: 533-541.
51. Tokarski K, Bobula B, Kusek M, Hess G. The 5-HT(7) receptor antagonist SB 269970 counteracts restraint stressinduced attenuation of long-term potentiation in rat frontal cortex. J Physiol Pharmacol 2011; 62: 663-667.
52. Nagahara AH. Tuszynski MH. Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov 2011; 10: 209-219.
53. Bejot Y, Prigent-Tessier A, Cachia C, et al. Time-dependent contribution of non neuronal cells to BDNF production after ischemic stroke in rats. Neurochem Int 2011; 58: 102-111.
54. Naert G, Maurice T, Tapia-Arancibia L, Givalois L. Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats. Psychoneuroendocrinology 2007; 32: 1062-1078.
55. Corpechot C, Robel P, Axelson M, Sjovall J, Baulieu EE. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci USA 1981; 78: 4704-4707.
56. Baulieu EE, Robel P. Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J Endocrinol 1996; 150 (Suppl.): S221-S239.
57. Baulieu EE. Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 1998; 23: 963-987.
58. Corpechot C, Synguelakis M, Talha S, Axelson M, Sjovall J, Vihko R, Baulieu EE, Robel P. Pregnenolone and its sulfate ester in the rat brain. Brain Res 1983; 270: 119-125.
59. Karishma KK, Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone induced suppression. Eur J Neurosci 2002; 16: 445-453.
60. Leyhe T, Stransky E, Eschweiler GW, Buchkremer G, Laske C. Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease. Eur Arch Psychiatry Clinl Neurosci March 2008; 258: 124-128.
61. Kotani S, Yamauchi T, Teramoto T, Ogura H. Donepezil, an acetylcholinesterase inhibitor, enhances adult hippocampal neurogenesis. Chem Biol Interact. 2008; 175: 227-230.